» Articles » PMID: 22495510

Extracellular Histones Inhibit Efferocytosis

Overview
Journal Mol Med
Publisher Biomed Central
Date 2012 Apr 13
PMID 22495510
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The uptake and clearance of apoptotic cells by macrophages and other phagocytic cells, a process called efferocytosis, is a major component in the resolution of inflammation. Increased concentrations of extracellular histones are found during acute inflammatory states and appear to contribute to organ system dysfunction and mortality. In these studies, we examined the potential role of histones in modulating efferocytosis. We found that phagocytosis of apoptotic neutrophils or thymocytes by macrophages was significantly diminished in the presence of histones H3 or H4, but not histone H1. Histone H3 demonstrated direct binding to macrophages, an effect that was diminished by preincubation of macrophages with the opsonins growth arrest-specific gene 6 (Gas6) and milk fat globule-epidermal growth factor (EGF) 8 (MFG-E8). Incubation of histone H3 with soluble α(v)β₅ integrin and Mer, but not with α(v)β₃, diminished its binding to macrophages. Phagocytosis of apoptotic cells by alveolar macrophages in vivo was diminished in the presence of histone H3. Incubation of histone H3 with activated protein C, a treatment that degrades histones, abrogated its inhibitory effects on efferocytosis under both in vitro and in vivo conditions. The present studies demonstrate that histones have inhibitory effects on efferocytosis, suggesting a new mechanism by which extracellular histones contribute to acute inflammatory processes and tissue injury.

Citing Articles

From inside to outside: exploring extracellular antimicrobial histone-derived peptides as multi-talented molecules.

Munoz-Camargo C, Cruz J J Antibiot (Tokyo). 2024; 77(9):553-568.

PMID: 38871806 PMC: 11347383. DOI: 10.1038/s41429-024-00744-0.


Extracellular mixed histones are neurotoxic and modulate select neuroimmune responses of glial cells.

Da Silva D, Richards C, McRae S, Riar I, Yang S, Zurfluh N PLoS One. 2024; 19(4):e0298748.

PMID: 38630734 PMC: 11023449. DOI: 10.1371/journal.pone.0298748.


Cellular mechanisms underlying the impairment of macrophage efferocytosis.

Ma Y, Kemp S, Yang X, Wu M, Yuan S Immunol Lett. 2023; 254:41-53.

PMID: 36740099 PMC: 9992097. DOI: 10.1016/j.imlet.2023.02.001.


Sputum from patients with primary ciliary dyskinesia contains high numbers of dysfunctional neutrophils and inhibits efferocytosis.

Blanter M, Cockx M, Wittebols L, Abouelasrar Salama S, De Bondt M, Berghmans N Respir Res. 2022; 23(1):359.

PMID: 36528664 PMC: 9758951. DOI: 10.1186/s12931-022-02280-7.


Inhaled Pro-Efferocytic Nanozymes Promote Resolution of Acute Lung Injury.

Ji H, Zhang C, Xu F, Mao Q, Xia R, Chen M Adv Sci (Weinh). 2022; 9(26):e2201696.

PMID: 35859230 PMC: 9475552. DOI: 10.1002/advs.202201696.


References
1.
Andersson U, Tracey K . HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011; 29:139-62. PMC: 4536551. DOI: 10.1146/annurev-immunol-030409-101323. View

2.
Yang Y, Friggeri A, Banerjee S, Bdeir K, Cines D, Liu G . Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils. Am J Respir Crit Care Med. 2010; 182(12):1516-23. PMC: 3029937. DOI: 10.1164/rccm.201003-0452OC. View

3.
Armstrong A, Ravichandran K . Phosphatidylserine receptors: what is the new RAGE?. EMBO Rep. 2011; 12(4):287-8. PMC: 3077256. DOI: 10.1038/embor.2011.41. View

4.
Blasi F, Sidenius N . Efferocytosis: another function of uPAR. Blood. 2009; 114(4):752-3. DOI: 10.1182/blood-2009-05-220657. View

5.
Cui T, Miksa M, Wu R, Komura H, Zhou M, Dong W . Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion. Am J Respir Crit Care Med. 2009; 181(3):238-46. PMC: 2817813. DOI: 10.1164/rccm.200804-625OC. View